PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,869 Cr | ₹9,151 Cr | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr |
What is the latest Revenue of PIRAMAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,869 Cr |
| Mar2025 | ₹9,151 Cr |
| Mar2024 | ₹8,171 Cr |
| Mar2023 | ₹7,082 Cr |
| Mar2022 | ₹6,559 Cr |
How is Revenue of PIRAMAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,869 Cr | -3.08 | |
| Mar2025 | ₹9,151 Cr | 11.99 | |
| Mar2024 | ₹8,171 Cr | 15.39 | |
| Mar2023 | ₹7,082 Cr | 7.97 | |
| Mar2022 | ₹6,559 Cr | - | |
Compare Revenue of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹24,116.5 Cr | 1.2% | 5% | -16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.2% |
5% |
-16.5% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses